Julie Ann M. Luk
About Julie Ann M. Luk
Julie Ann M. Luk serves as the Director of Clinical Operations and Early Portfolio Management at AlloVir, where she has worked since 2021. She has extensive experience in clinical operations and regulatory affairs, having held positions at Merck, SST Corporation, and Schering-Plough Research Institute.
Current Role at AlloVir
Julie Ann M. Luk serves as the Director of Clinical Operations and Early Portfolio Management at AlloVir. She has held this position since 2021, contributing her expertise in optimizing business strategies and enhancing partnerships. In her role, she focuses on managing clinical trials and overseeing the early stages of portfolio management, ensuring that operations align with the company's objectives.
Previous Experience in Clinical Operations
Prior to her current role, Julie Ann M. Luk accumulated significant experience in clinical operations. She worked at Merck for 16 years as an Associate Principal Scientist in Early Stage Development Operations. Her earlier roles include serving as a Clinical Information Specialist at Schering-Plough Research Institute and as a Regulatory Affairs Specialist at SST Corporation. This extensive background has equipped her with a comprehensive understanding of clinical trial management.
Education and Qualifications
Julie Ann M. Luk studied at Rutgers University - Newark. She also attended The George Washington University School of Medicine and Health Sciences, where she earned a Graduate Certificate in Clinical Research Administration. Her educational background supports her expertise in clinical operations and regulatory affairs.
Specialization and Expertise
Julie Ann M. Luk specializes in optimizing business strategies and strengthening cross-functional partnerships. She has a proven track record in developing and improving company infrastructure related to clinical operations. Her expertise extends to managing clinical trials across all phases, from Phase 0 to Phase 4, demonstrating her comprehensive knowledge of the clinical development process.